GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (FRA:818) » Definitions » Debt-to-Revenue

Zylox-Tonbridge Medical Technology Co (FRA:818) Debt-to-Revenue : 0.11 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Zylox-Tonbridge Medical Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €10.1 Mil. Zylox-Tonbridge Medical Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.3 Mil. Zylox-Tonbridge Medical Technology Co's annualized Revenue for the quarter that ended in Jun. 2024 was €93.7 Mil. Zylox-Tonbridge Medical Technology Co's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 was 0.11.


Zylox-Tonbridge Medical Technology Co Debt-to-Revenue Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co Debt-to-Revenue Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial 1.24 0.05 0.04 0.11 0.12

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.09 0.11 0.11

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's Debt-to-Revenue

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zylox-Tonbridge Medical Technology Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Debt-to-Revenue falls into.


;
;

Zylox-Tonbridge Medical Technology Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Zylox-Tonbridge Medical Technology Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(6.937 + 0.239) / 67.778
=0.11

Zylox-Tonbridge Medical Technology Co's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(10.1 + 0.303) / 93.734
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2024) Revenue data.


Zylox-Tonbridge Medical Technology Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zylox-Tonbridge Medical Technology Co Business Description

Traded in Other Exchanges
Address
270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB).

Zylox-Tonbridge Medical Technology Co Headlines

No Headlines